The Alliance

Spotlight Series

The executive insight series is designed for healthcare senior executives. These brief, bi-annual issues focus on topics relevant to top-tier hospital leadership. For each topic, you can find related references, resources, and tools.

Spotlight Series Past Issues

Exclusive Access

Take advantage of our 2021 professional partnership levels of support to receive exclusive early access to The Alliance Insight Series publications.

You’ll still have access to all our materials when they go online one month after publication.

*Bronze Circle is a one-time introductory level for first-time Professional Partner organizations. While this opportunity carries limited benefits, it is intended to provide introductory access to The Alliance’s diverse programs and learning solutions. Current Professional Partners are exempt from this option.
Arzt Bringt Organspende In OP Für Organtransplantation

Life after Regions: Exploring Continuous Distribution Systems

Life After Regions

Exploring Continuous Distribution Systems Health disparities continue to be a challenge that we, as a community, must address for the well being and future of our patients. In the field of transplantation, there are vast geographic disparities. Prior to the continuous distribution mandate, in liver transplantation alone, 7 out of 11 regions had a relative rate of transplantation that differed significantly from the nation, a clear sign that change was in order. To aid the closing of this health gap, the OPTN Board of Directors endorsed the development of continuous distribution systems in December 2018.

What is Continuous Distribution?

Continuous distribution utilizes a statistical formula that combines the following key clinical factors:

  • Medical urgency
  • Placement efficiency
  • Outcomes score
  • Candidate access score

The formula then creates a relative distribution score. The relative distribution score is considered without any absolute geographic boundary so that candidates who have the best combinations of factors receive priority.

Patients Composite Allocation Score

Patients Composite Allocation Score

While this is an ongoing process, there are some updates that have already been made to the distribution systems for heart, lung, liver, kidney, pancreas, and Vascularized Composite Allografts (VCAs). In the future, we can expect to see further updates regarding next steps for lowering disparities within our patient populations. The current features and effects of these changes include:

Heart Allocation System

  • Continuous distribution became effective Jan. 9, 2019 using 250 nm
  • Six new medical urgency statuses (Click here for more information)
  • Hearts can be distributed up to 500 miles + DSA for the new Statuses 1 & 2
  • Expected effect: reduce waiting list deaths

Liver Allocation System

  • New policy implemented in Feb. 2020, now using 500nm – removes DSAs and Regions from liver distribution
  • National Liver Review Board – implemented April 2019
  • Enhanced Liver Distribution/Acuity Circle Liver Distribution & Allocation – implemented February 2020
  • Distribution concepts are in the process of being modeled to utilize fixed distance circles around the donor hospital ▷ Expected effect: More transplants for the sickest candidates and broader

Lung Allocation System

  • Designated Service Areas (DSAs) were removed in 2017, now using 500nm
  • Ongoing monitoring and discussions continue within UNOS Research (6 Month Report of DSA Removal) and the Thoracic Committee ▷ Expected effect: More transplants for the sickest candidates

Kidney & Pancreas Allocation System

  • Implementation of Kidney and Pancreas circles by December 2020
  • Replace DSA and Region with a fixed distance circle with a radius of 250 nm
  • Add proximity points to a candidate’s total allocation score based on the distance of candidate’s center from the donor hospital ▷ Expected effect: More transplants for the sickest candidates

The content of this issue is based on a webinar presentation by David C. Mulligan, MD, FACS, FAASLD, FAST, Yale University/Yale New Haven Health System. A special thanks to Dr. Mulligan for his contributions to this in-service.

A Special Thanks to This Series’ Contributors

David Mulligan
Speaker
David Mulligan
MD, FACS, FAASLD, FAST
Yale University
Deanna Fenton
About the Editor |
Deanna Fenton

Deanna is a knowledgeable and versatile professional with diverse experiences in healthcare, client relations, marketing, project management and demonstrated skills in leadership and advocacy. Prior to joining The Alliance, she worked in Hospital Development at her local OPO in the state of New Jersey where she served as the clinical liaison to a number of Level 1 Trauma & Neuroscience centers as well as community hospitals. Her personal connection as a donor family and friend fuels her passion to support her colleagues across the donation-transplantation continuum through the development of valuable educational resources that ultimately boost performance and improve outcome measures. Deanna holds a Bachelor of Arts in Psychology and a minor degree in Public Health from Montclair State University. In her spare time, Deanna enjoys visiting vineyards, spending time with her family, and traveling in hopes of visiting all seven wonders of the world.

Advancing All.

The Alliance is not a membership organization and therefore relies on annual voluntary financial support from OPOs and transplant programs who find value in our programs and initiatives.

We invite you to join us as a 2021 professional partner

Menu